mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.003 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |